Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Gravimetric antigen detection utilizing antibody-modified lipid bilayers

Author:
  • C Larsson
  • H Bramfeldt
  • Christer Wingren
  • Carl Borrebaeck
  • F Hook
Publishing year: 2005
Language: English
Pages: 72-80
Publication/Series: Analytical Biochemistry
Volume: 345
Issue: 1
Document type: Journal article
Publisher: Elsevier

Abstract english

Lipid bilayers containing 5% nitrilotriacetic acid (NTA) lipids supported on SiO2 have been used as a template for immobilization of oligohistidine-tagged single-chained antibody fragments (scFvs) directed against cholera toxin. It was demonstrated that histidine-tagged scFvs could be equally efficiently coupled to an NTA-Ni2+-containing lipid bilayer from a purified sample as from an expression supernatant, thereby providing a coupling method that eliminates time-consuming protein prepurification steps. Irrespective of whether the coupling was made from the unpurified or purified antibody preparation, the template proved to be efficient for antigen (cholera toxin) detection, verified using quartz crystal microbalance with dissipation monitoring. In addition, via a secondary amplification step using lipid vesicles containing GM, (the natural membrane receptor for cholera toxin), the detection limit of cholera toxin was less than 750 pM. To further strengthen the coupling of scFvs to the lipid bilayer, scFvs containing two histidine tags, instead of just one tag, were also evaluated. The increased coupling strength provided via the bivalent anchoring significantly reduced scFv displacement in complex solutions containing large amounts of histidine-containing proteins, verified via cholera toxin detection in serum. (C) 2005 Elsevier Inc. All rights reserved.

Keywords

  • Immunology in the medical area

Other

Published
  • ISSN: 1096-0309
Carl B
Carl Borrebaeck
E-mail: carl [dot] borrebaeck [at] immun [dot] lth [dot] se

Professor

Department of Immunotechnology

313k1

90

Director

Create Health

+46 46 222 96 13

313k1

90